Wednesday, May 27, 2009

MAP Pharmaceuticals’ experimental migraine drug Levadex gains in test, and shares in its maker soar http://tr.im/myEw
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)